Primary tumorectomy promotes angiogenesis and pulmonary metastasis in osteosarcoma-bearing nude mice

Acta Cirurgica Brasileira

Volumn 28, Issue 3, 2013, Pages 190-194

  Wang, Zhi Yuan ^a   Mei, Jiong ^a   Gao, You Shui ^b   Ni, Ming ^a   Yao, Bin ^a  

^a TONGJI UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Endostatins; Mice; Neplasm metastasis; Osteosarcoma; Tumor resistance; Vascular endothelial growth factor a

Indexed keywords

ENDOSTATIN; HEMOGLOBIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CANCER SURGERY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PROTEIN EXPRESSION; SPECTROPHOTOMETRY;

ANIMALS; BONE NEOPLASMS; COLLAGEN; DRUG COMBINATIONS; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMOGLOBINS; LAMININ; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; OSTEOSARCOMA; PROTEOGLYCANS; TIME FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876926198     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502013000300006     Document Type: Article

References (26)

1. Longhi A, Errani C, De Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev. 2006;32:423-36.
2. Tomoda R, Seto M, Hioki Y, Sonosa J, Matsumine A, Kusuzaki K, Uchida A. Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma. Clin Exp Metastasis. 2005;22:559-64.
3. Cao Y, O'Reilly MS, Marshall B, Flynn E, Ji RW, Folkman J. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J Clin Invest. 1998;101:1055-63.
4. Pakos EE, Nearchou AD, Grimer RJ, Koumoullis HD, Abudu A, Bramer JA, Jeys LM, Franchi A, Scoccianti G, Campanacci D, Capanna R, Aparicio J, Tabone MD, Holzer G, Abdolvahab F, Funovics P, Dominkus M, Ilhan I, Berrak SG, Patino-Garcia A, Sierrasesumaga L, San-Julian M, Garraus M, Petrilli AS, Filho RJ, Macedo CR, Alves MT, Seiwerth S, Nagarajan R, Cripe TP, Ioannidis JP. Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer. 2009; 45:2367-75.
5. Snyder CL, Saltzman DA, Ferrell KL, Thompson RC, Leonard AS. A new approach to the resection of pulmonary osteosarcoma metastases. Results of aggressive metastasectomy. Clin Orthop Relat Res. 1991;270:247-53.
6. Quan GM, Choong PF. Anti-angiogenic therapy for osteosarcoma. Cancer Metastasis Rev. 2006;25:707-13.
7. Tsunemi T, Nagoya S, Kaya M, Kawaguchi S, Wada T, Yamashita T, Ishii S. Postoperative progression of pulmonary metastasis in osteosarcoma. Clin Orthop Relat Res. 2003;407:159-66.
8. Kaya M, Wada T, Nagoya S, Yamashita T. Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin. J Orthop Sci. 2007;12:562-7.
9. Prehn RT. The inhibition of tumor growth by tumor mass. Cancer Res. 1991;51:2-4.
10. Prehn RT. Two competing influences that may explain concomitant tumor resistance. Cancer Res. 1993;53:3266-9.
11. Mei J, Ni M, Chen YX, Yao B, Gao YS, Yu XM, Wang ZY. Effects of primary tumor excision on angiogenesis and pulmonary metastasis in osteosarcoma-bearing nude mice. Zhonghua Zhong Liu Za Zhi. 2009;31:246-9.
12. Kaya M, Wada T, Nagoya S, Kawaguchi S, Isu K, Yamashita T. Concomitant tumour resistance in patients with osteosarcoma. A clue to a new therapeutic strategy. J Bone Joint Surg Br. 2004;86:143-7.
13. Li TS, Kaneda Y, Ueda K, Hamano K, Zempo N, Esato K. The influence of tumour resection on angiostatin levels and tumour growth-an experimental study in tumour-bearing mice. Eur J Cancer. 2001;37:2283-8.
14. Streck C, Zhang Y, Zhou J, Ng CY, Davidoff A. Endostatinmediated concomitant resistance in neuroblastoma. J Pediatr Surg. 2004;39:405-11.
15. Scharovsky OG, Binda MM, Rozados VR, Bhagat VR, Cher ML, Bonfil RD. Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance. Clin Exp Metastasis. 2004;21:177-83.
16. Binda MM, Matar P, González AD, Rozados VR, Gervasoni SI, Scharovsky OG, Bonfil RD. Differential production of angiostatin by concomitant antitumoral resistance-inducing cancer cells. Int J Cancer. 2002;100:14-21.
17. Kisker O, Onizuka S, Banyard J, Komiyama T, Becker CM, Achilles EG, Barnes CM, O'Reilly MS, Folkman J, Pirie-Shepherd SR. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Cancer Res. 2001;61:7298-304.
18. Bashford E, Murry JA, Cramer W. The natural and induced resistance of mice to the growth of cancer. Proc R Soc London. 1907;79:164-87.
19. Michelson S, Leith JT. A theoretical explanation of "concomitant resistance". Bull Math Biol. 1995;57:733-47.
20. Sacco MG, Caniatti M, Catò EM, Frattini A, Chiesa G, Ceruti R, Adorni F, Zecca L, Scanziani E, Vezzoni P. Liposome-delivered angiostatin strongly inhibits tumor growth and metastatization in a transgenic model of spontaneous breast cancer. Cancer Res. 2000;60:2660-5.
21. Volpert OV, Lawler J, Bouck NP. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci USA. 1998;95:6343-8.
22. Jia SF, Guan H, Duan XP, Kleinerman ES. VEGF165 is necessary to the metastatic potential of Fas- osteosarcoma cell but will not rescue the Fas+ cells. J Exp Ther Oncol. 2008;7:89-97.
23. Kerbel RS. Tumor angiogenesis. N Engl J Med. 2008;358:2039-49.
24. Gao YS, Mei J, Tong TL, Hu M, Xue HM, Cai XS. Inhibitory effects of VEGF-siRNA mediated by adenovirus on osteosarcoma-bearing nude mice. Cancer Biother Radiopharm. 2009;24:243-7.
25. Mei J, Gao Y, Zhang L, Cai X, Qian Z, Huang H, Huang W. VEGFsiRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro. Exp Oncol. 2008;30:29-34.
26. Wang JQ, Gao YS, Mei J, Xue HM, Wang SQ, Cai XS. Morphological changes in osteosarcoma xenografts in nude mice after inhibiting angiogenesis by Ad-VEGF-siRNA. Ai Zheng. 2009;28:581-6.